Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xylometazoline for Obstructive Sleep Apnea with Nasal Congestion
NCT00630474Phase 4Completed
- Sponsor
- University of Zurich
- Start
- Jan 2004
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in obstructive sleep apnea syndrome (OSAS) comparing xylometazoline with placebo (2 arms). Primary endpoints: Sleep related breathing disturbances at 1 week, Sleep efficiency at 1 week and 1 more. Started Jan 2004; status: completed.
02
Drugs
xylometazoline
03
Conditions
obstructive sleep apnea syndrome (OSAS)
Beyond the preview
Go deeper on NCT00630474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630474.